Status:
WITHDRAWN
Characterization of Rhythmicity Profiles of Bradykinin-mediated Angioedema Attacks Using a Tracking Smartphone Application.
Lead Sponsor:
University Hospital, Lille
Conditions:
Bradykinin-mediated Angioedema
Eligibility:
All Genders
18+ years
Brief Summary
Bradykinin-mediated angioedema is a rare and disabling disease, characterized by the occurrence of attacks marked by localized swelling of skin, but also of the airways, which can be life-threatening....
Eligibility Criteria
Inclusion
- Diagnosis of bradykinin-mediated angioedema
- Age \> 18
- Having a smartphone
- Non opposition to answer the questionnaire
Exclusion
- Patients with other type (histaminergic) angioedema
- Patient unable or unwilling to use a smartphone application
- Opposition to the research
- Minor or protected adult
- Person deprived of liberty
Key Trial Info
Start Date :
August 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05304091
Start Date
August 1 2022
End Date
August 1 2023
Last Update
December 26 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.